Dr. Beth Anne Baber PhD MBA
is a scientist and a social-impact entrepreneur that addresses barriers to improving patient outcomes through the convergence of technology, patient engagement, and policy. She’s a longtime patient advocate working closely with Congress, federal agencies, and the former White House on precision medicine, cancer initiatives, and health policy.
Dr. Baber has more than 20 years of academic research experience in signal transduction, cancer genetics, virology, immunology, neurobiology, and developmental biology. Her research focused on the understanding of DNA damage repair following exposure to radiation and chemotherapeutic agents that led to publications in major scientific journals, including Science and Nature.